War on Cancer 2015 will bring together the most influential leaders in oncology from around Europe to explore and shape the dialogue on cancer. Join pharmaceutical, health care, scientific and government specialists on October 20th 2015 to discuss the leading initiatives in policy and financing, innovation in prevention, treatment and diagnosis and new methods of community engagement. The Summit is sponsored by Merck Serono, Novartis Oncology, EY, Varian Medical Systems and Elekta.
Key topics and confirmed speakers include:
-Towards a Unified European Oncology Framework, led by John Ryan, Acting Director – Public Health Directorate Health and Food Safety Directorate General, European Commission
-Creating a Virtuous Circle in Disease Research and Development, led by Peter Lebowitz, Head of Global Oncology Research and Development, Janssen Pharmaceutical Companies of Johnson & Johnson
-The Regulatory Perspective: Rallying The European Community Behind a Multi-Stakeholder Adaptive Licensing Approach, led by Hans-Georg Eichler, Senior Medical Officer, European Medicines Agency
-A Vision for the future—Cancer Care In 2030, led by Patrick Soon-Shiong, Chairman and Chief Executive Officer, NantWorks
Key topics and confirmed speakers include:
-Towards a Unified European Oncology Framework, led by John Ryan, Acting Director – Public Health Directorate Health and Food Safety Directorate General, European Commission
-Creating a Virtuous Circle in Disease Research and Development, led by Peter Lebowitz, Head of Global Oncology Research and Development, Janssen Pharmaceutical Companies of Johnson & Johnson
-The Regulatory Perspective: Rallying The European Community Behind a Multi-Stakeholder Adaptive Licensing Approach, led by Hans-Georg Eichler, Senior Medical Officer, European Medicines Agency
-A Vision for the future—Cancer Care In 2030, led by Patrick Soon-Shiong, Chairman and Chief Executive Officer, NantWorks
